Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBarr (A.G.) Regulatory News (BAG)

Share Price Information for Barr (A.G.) (BAG)

Share Price is delayed by 15 minutes
Get Live Data
633.00    -4.00 (-0.63%)
Bid:
633.00
Ask:
634.00
Spread: 1.00 (0.158%)
Market Cap: £702.48m
BAG Live PriceLast checked at - London Stock Exchange

Intraday Barr (A.G.) Share Chart

Pre Close trading update

24 Jan 2013 07:00

RNS Number : 2468W
Barr(A.G.) PLC
24 January 2013
 



A.G. BARR p.l.c.

 

Pre Close trading update

 

 

A.G. BARR p.l.c., the soft drinks group, today announces that trading in the final quarter of the financial year is expected to have performed ahead of the total soft drinks market.

 

It is anticipated that total sales in the final quarter will be over 5% ahead of the prior year. The performance in the final quarter is particularly pleasing given the double digit year on year growth in the same period last year. This will give a full year revenue expectation of circa £253 million reflecting a year on year growth of circa 7%.

 

Despite very poor summer weather and a competitive market place, all of our core brands grew in the year. IRN-BRU performed well in challenging conditions with a very positive consumer response to the 'IRN-BRU gets you through' marketing campaign. Rubicon and KA have continued to build on strong prior year performances and the Barr brand has maintained its double digit growth performance. Rockstar has seen a step change in its performance, benefiting from a buoyant energy category and strong trading execution across the year.

 

The operational performance of the business has improved across the financial year with excellent customer service across the final quarter.

 

Our investment in the Crossley site at Milton Keynes is progressing well - on time and to budget. It is expected that commercial production will commence in the summer of 2013.

 

Over the period our free cashflow generation and balance sheet have remained strong, with net debt in line with expectations allowing for the impact of the expenditure on the Milton Keynes project and the acceleration of the dividend paid in January 2013.

 

A.G. Barr remains on course to meet its expectations for the financial year ending 26 January 2013.

 

Barr Britvic merger

 

There is no further update following the rescheduled expected OFT decision date of 13 February 2013. As previously announced, the parties continue to work towards the implementation of the merger, with the effective date currently expected to be 26 February 2013.

 

Outlook

 

A.G. Barr has delivered a robust performance in a market place impacted by the combination of very poor summer weather and the ongoing economic challenges faced by consumer goods companies, notably raw material cost pressures and inconsistent consumer demand. Looking forward, it is unlikely that these challenges will materially change, however we remain cautiously optimistic that the combination of our proven operating model, continued focus on efficiency, strong brand equity, sound balance sheet and growth potential leave us well placed to continue to build on this performance.

 

A.G. Barr intends to announce its full year financial results on 21 March 2013.

 

24 January 2013

 

A.G. Barr

Tel: 01236 852400

Roger White, Chief Executive

Alex Short, Finance Director

College Hill

Tel: 020 7457 2020

Justine Warren

Matthew Smallwood

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTPGUUAGUPWGMW
Date   Source Headline
22nd Apr 202510:24 amRNSAnnual Financial Report
9th Apr 202511:23 amRNSDirector/PDMR Shareholding
8th Apr 20253:29 pmRNSDirector/PDMR Shareholding
25th Mar 20257:00 amRNSResults for year ended 25 January 2025
10th Mar 20252:04 pmRNSDirector/PDMR Shareholding
10th Feb 20253:59 pmRNSDirector/PDMR Shareholding - Replacement
10th Feb 20253:10 pmRNSDirector/PDMR Shareholding
28th Jan 20257:00 amRNSTrading Update
20th Jan 202511:00 amRNSDirector Declaration
9th Jan 20254:42 pmRNSDirector/PDMR Shareholding
7th Jan 202511:44 amRNSNotice of Trading Update
17th Dec 20249:20 amRNSDirector Declaration
9th Dec 20241:50 pmRNSDirector/PDMR Shareholding
12th Nov 20241:35 pmRNSDirector/PDMR Shareholding
4th Nov 202410:54 amRNSDirector/PDMR Shareholding
9th Oct 202410:10 amRNSDirector/PDMR Shareholding
24th Sep 20247:00 amRNSInterim Results
9th Sep 20241:03 pmRNSDirector/PDMR Shareholding
4th Sep 20249:08 amRNSDirector Declaration
20th Aug 20248:39 amRNSDirector/PDMR Shareholding
8th Aug 20241:10 pmRNSDirector/PDMR Shareholding
30th Jul 20247:00 amRNSTrading Statement
8th Jul 202412:03 pmRNSDirector/PDMR Shareholding
4th Jul 202410:17 amRNSNotice of Results
1st Jul 20244:50 pmRNSDirector/PDMR Shareholding
21st Jun 20243:22 pmRNSDirector/PDMR Shareholding
10th Jun 20241:51 pmRNSDirector/PDMR Shareholding
10th Jun 20241:48 pmRNSDirector/PDMR Shareholding
4th Jun 20249:36 amRNSDirector/PDMR Shareholding
31st May 20241:54 pmRNSResult of AGM
9th May 202411:28 amRNSDirector/PDMR Shareholding
7th May 20249:06 amRNSDirector/PDMR Shareholding
23rd Apr 20249:17 amRNSAnnual Financial Report
15th Apr 20242:59 pmRNSDirector/PDMR Shareholding
9th Apr 20243:46 pmRNSDirector/PDMR Shareholding - replacement
9th Apr 20243:36 pmRNSDirector/PDMR Shareholding
9th Apr 20241:05 pmRNSDirector/PDMR Shareholding - replacement
9th Apr 202412:50 pmRNSDirector/PDMR Shareholding
5th Apr 20242:26 pmRNSDirector/PDMR Shareholding
2nd Apr 202411:15 amRNSDirector/PDMR Shareholding
28th Mar 202410:10 amRNSDirector/PDMR Shareholding
26th Mar 20247:00 amRNSDirectorate changes announcement
26th Mar 20247:00 amRNSFinal Results
14th Mar 20243:01 pmRNSBusiness reorganisation
11th Mar 20248:39 amRNSDirector/PDMR Shareholding
27th Feb 20241:47 pmRNSHolding(s) in Company
8th Feb 20242:03 pmRNSDirector/PDMR Shareholding - Replacement
8th Feb 20241:51 pmRNSDirector/PDMR Shareholding
1st Feb 20247:00 amRNSBoard succession announcement
1st Feb 20247:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.